世界の禁煙薬市場予測（～2028年）：NRTs製品、ニコチンフリー製品

• 英文タイトル：Global Smoking Cessation Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8963 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

禁煙薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の禁煙薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 禁煙薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・NRTs製品、ニコチンフリー製品 用途別セグメントは次のように区分されます。 ・病院薬局、小売薬局、オンライン薬局、その他 世界の禁煙薬市場の主要な市場プレーヤーは以下のとおりです。 ・GSK、Pfizer、Kimree Technology、Johnson & Johnson、Novartis、Dr. Reddy's Laboratories、The Harvard Drug Group、Perrigo Company、Fontem Ventures、Smoke Away 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、禁煙薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な禁煙薬メーカーの企業概要、2019年～2022年までの禁煙薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な禁煙薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別禁煙薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの禁煙薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での禁煙薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および禁煙薬の産業チェーンを掲載しています。 ・第13、14、15章では、禁煙薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GSK、Pfizer、Kimree Technology、Johnson & Johnson、Novartis、Dr. Reddy's Laboratories、The Harvard Drug Group、Perrigo Company、Fontem Ventures、Smoke Away ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：NRTs製品、ニコチンフリー製品 ・用途別分析2017年-2028年：病院薬局、小売薬局、オンライン薬局、その他 ・禁煙薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・禁煙薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・禁煙薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・禁煙薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・禁煙薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Smoking Cessation Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Smoking Cessation Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Smoking Cessation Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While NRTs Products segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Smoking Cessation Drugs include GSK, Pfizer, Kimree Technology, Johnson & Johnson, and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Smoking Cessation Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
NRTs Products
Nicotine-Free Products
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
The key market players for global Smoking Cessation Drugs market are listed below:
GSK
Pfizer
Kimree Technology
Johnson & Johnson
Novartis
Dr. Reddy’s Laboratories
The Harvard Drug Group
Perrigo Company
Fontem Ventures
Smoke Away
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Smoking Cessation Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Smoking Cessation Drugs, with price, sales, revenue and global market share of Smoking Cessation Drugs from 2019 to 2022.
Chapter 3, the Smoking Cessation Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Smoking Cessation Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Smoking Cessation Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Smoking Cessation Drugs.
Chapter 13, 14, and 15, to describe Smoking Cessation Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Smoking Cessation Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Smoking Cessation Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 NRTs Products
1.2.3 Nicotine-Free Products
1.3 Market Analysis by Application
1.3.1 Overview: Global Smoking Cessation Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Smoking Cessation Drugs Market Size & Forecast
1.4.1 Global Smoking Cessation Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Smoking Cessation Drugs Sales in Volume (2017-2028)
1.4.3 Global Smoking Cessation Drugs Price (2017-2028)
1.5 Global Smoking Cessation Drugs Production Capacity Analysis
1.5.1 Global Smoking Cessation Drugs Total Production Capacity (2017-2028)
1.5.2 Global Smoking Cessation Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Smoking Cessation Drugs Market Drivers
1.6.2 Smoking Cessation Drugs Market Restraints
1.6.3 Smoking Cessation Drugs Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Smoking Cessation Drugs Product and Services
2.1.4 GSK Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Smoking Cessation Drugs Product and Services
2.2.4 Pfizer Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Kimree Technology
2.3.1 Kimree Technology Details
2.3.2 Kimree Technology Major Business
2.3.3 Kimree Technology Smoking Cessation Drugs Product and Services
2.3.4 Kimree Technology Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Smoking Cessation Drugs Product and Services
2.4.4 Johnson & Johnson Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Smoking Cessation Drugs Product and Services
2.5.4 Novartis Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Dr. Reddy’s Laboratories
2.6.1 Dr. Reddy’s Laboratories Details
2.6.2 Dr. Reddy’s Laboratories Major Business
2.6.3 Dr. Reddy’s Laboratories Smoking Cessation Drugs Product and Services
2.6.4 Dr. Reddy’s Laboratories Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 The Harvard Drug Group
2.7.1 The Harvard Drug Group Details
2.7.2 The Harvard Drug Group Major Business
2.7.3 The Harvard Drug Group Smoking Cessation Drugs Product and Services
2.7.4 The Harvard Drug Group Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Perrigo Company
2.8.1 Perrigo Company Details
2.8.2 Perrigo Company Major Business
2.8.3 Perrigo Company Smoking Cessation Drugs Product and Services
2.8.4 Perrigo Company Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Fontem Ventures
2.9.1 Fontem Ventures Details
2.9.2 Fontem Ventures Major Business
2.9.3 Fontem Ventures Smoking Cessation Drugs Product and Services
2.9.4 Fontem Ventures Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Smoke Away
2.10.1 Smoke Away Details
2.10.2 Smoke Away Major Business
2.10.3 Smoke Away Smoking Cessation Drugs Product and Services
2.10.4 Smoke Away Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Smoking Cessation Drugs Breakdown Data by Manufacturer
3.1 Global Smoking Cessation Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Smoking Cessation Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Smoking Cessation Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Smoking Cessation Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Smoking Cessation Drugs Manufacturer Market Share in 2021
3.5 Global Smoking Cessation Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Smoking Cessation Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Smoking Cessation Drugs Market Size by Region
4.1.1 Global Smoking Cessation Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Smoking Cessation Drugs Revenue by Region (2017-2028)
4.2 North America Smoking Cessation Drugs Revenue (2017-2028)
4.3 Europe Smoking Cessation Drugs Revenue (2017-2028)
4.4 Asia-Pacific Smoking Cessation Drugs Revenue (2017-2028)
4.5 South America Smoking Cessation Drugs Revenue (2017-2028)
4.6 Middle East and Africa Smoking Cessation Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Smoking Cessation Drugs Sales in Volume by Type (2017-2028)
5.2 Global Smoking Cessation Drugs Revenue by Type (2017-2028)
5.3 Global Smoking Cessation Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Smoking Cessation Drugs Sales in Volume by Application (2017-2028)
6.2 Global Smoking Cessation Drugs Revenue by Application (2017-2028)
6.3 Global Smoking Cessation Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Smoking Cessation Drugs Sales by Type (2017-2028)
7.2 North America Smoking Cessation Drugs Sales by Application (2017-2028)
7.3 North America Smoking Cessation Drugs Market Size by Country
7.3.1 North America Smoking Cessation Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Smoking Cessation Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Smoking Cessation Drugs Sales by Type (2017-2028)
8.2 Europe Smoking Cessation Drugs Sales by Application (2017-2028)
8.3 Europe Smoking Cessation Drugs Market Size by Country
8.3.1 Europe Smoking Cessation Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Smoking Cessation Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Smoking Cessation Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Smoking Cessation Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Smoking Cessation Drugs Market Size by Region
9.3.1 Asia-Pacific Smoking Cessation Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Smoking Cessation Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Smoking Cessation Drugs Sales by Type (2017-2028)
10.2 South America Smoking Cessation Drugs Sales by Application (2017-2028)
10.3 South America Smoking Cessation Drugs Market Size by Country
10.3.1 South America Smoking Cessation Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Smoking Cessation Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Smoking Cessation Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Smoking Cessation Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Smoking Cessation Drugs Market Size by Country
11.3.1 Middle East & Africa Smoking Cessation Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Smoking Cessation Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Smoking Cessation Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Smoking Cessation Drugs
12.3 Smoking Cessation Drugs Production Process
12.4 Smoking Cessation Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Smoking Cessation Drugs Typical Distributors
13.3 Smoking Cessation Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---